Veeva Systems || OpenData Abzena Ltd
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

23

Jul 2021

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain

Acorda Therapeutics Inc today announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals SA ESTEVE to commercialize INBRIJA mg levodopa inhalation powder hard capsules in Spain INBRIJA is indicated in the EU for the intermittent treatment of episodic motor flu...

23

Jul 2021

Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings

Pfizer Inc announced today that the US Food and Drug Administration FDA has notified the company that it will not meet the Prescription Drug User Fee Act PDUFA goal dates for the New Drug Application for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatiti...

22

Jul 2021

Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

Pfizer Inc and BioNTech SE announced the signing of a letter of intent with The Biovac Institute Pty Ltd known as Biovac a Cape Townbased South African biopharmaceutical company to manufacture the PfizerBioNTech COVID Vaccine for distribution within the African Union Biovac will perform manufacturin...

22

Jul 2021

LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics

LEXEO Therapeutics a fully integrated clinicalstage gene therapy company advancing diseasemodifying treatments for genetic conditions today announced that it has acquired Stelios Therapeutics an earlystage company developing novel adenoassociated virus AAVmediated gene therapies for rare genetic car...

press releasesRead more...

23

Jul 2021

Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

Eisai Co Ltd and Merck Co Inc Kenilworth NJ USA known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has approved the combination of LENVIMA the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai plus KEYTRUDA t...

23

Jul 2021

Eppendorf CryoCube® F440 ULT freezers now all-green

Eppendorf continues to follow the path of sustainability by redesigning the L ULT freezer class The wellknown standardsized ultralow temperature ULT freezer is now completely equipped with futureproof green cooling liquids and green insulation foam as well as better performance

22

Jul 2021

Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue

Antares Pharma Inc a specialty pharmaceutical company today announced that the US Food and Drug Administration FDA has accepted the Investigational New Drug Application IND for ATRS for adrenal crisis rescue The active IND enables Antares to initiate a Phase clinical study for ATRS for the treatmen...

22

Jul 2021

Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)

Adagene Inc a platformdriven clinicalstage biopharmaceutical company committed to transforming the discovery and development of novel antibodybased immunotherapies today announced that it has entered into the clinical trial collaboration and supply agreement with Merck known as MSD outside the Unite...

EventsRead more...

28 - 29

Jul 2021

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    GE Healthcare

    President & CEO

    Our current business focus and strengths are in the areas of bioprocessing proteins cellular analysis cell handling and tools for cell therapy Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provide We are particularly excited about the sample collection and storage opportunity with the FTA product lineWe have a stron...
  • Research Insights

    Biosensor-based engineering of biosynthetic pathways

    Biosynthetic pathways provide an enzymatic route from inexpensive renewable resources to valuable metabolic products such as pharmaceuticals and plastics Designing these pathways is challenging due to the complexities of biology Advances in the design and construction of genetic variants has enabled billions of cells each possessing a slightly different metabolic design to be rapidly generated However our abi

  • Case Studies

    Viral Clearance For Biopharmaceutical Downstream Processes

    Abstract Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals These studies are a key component of risk mitigation to reduce the potential for iatrogenic transmission of pathogenic viruses This paper reviews regulatory guidance and practical strategies for designing viral clearance studies Ess

  • Techno Trends

    Aegis Therapeutics\' Intravail Technology to Work in Pill Forms

    Aegis Therapeutics announced that it has developed a breakthrough technology Intravail absorption enhancement technology which would improve the bioavailability of drugs that are delivered through the nose It has solubility enhancement effects similar to that in solid dosage forms The technology being applied to a pill for the first time the formulation has enhanced...

  • White Papers

    Taking Fill Release Rates To A New Level

    Summary Gelatine capsules are among the most popular single unit dosage forms for drugs Rx overthecounter OTC products and food supplements While hard gelatine capsules are primarily used for powder applications soft gelatine capsules are the preferred dosage form for liquid pastelike or oilbased active ingredients In general soft shell capsules r

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...